Discovery of serum biomarkers of alcoholic fatty liver in a rodent model: C-reactive protein

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Liu, Shu Lin ^a   Cheng, Chun Chia ^b,c   Chang, Chun Chao ^d   Mai, Fu Der ^b,d,e   Wang, Chia Chi ^f   Lee, Shui Cheng ^c   Ho, Ai Sheng ^g   Chen, Ling Yun ^a   Chang, Jungshan ^b,d,e,h  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^g CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^h TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

alcoholic fatty liver; biomarker; C reactive protein; haptoglobin; two dimensional differential gel electrophoresis

Indexed keywords

AFAMIN PROTEIN; ALPHA FETOPROTEIN; C REACTIVE PROTEIN; HAPTOGLOBIN; HEAK SHOCK PROTEIN 75; HEAT SHOCK PROTEIN; INTERALPHA INHIBITOR H4 PROTEIN; PROTEIN; SERINE PROTEASE INHIBITOR KAZAL TYPE 5 PROTEIN; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN PREPEPTIDE; BIOLOGICAL MARKER;

ALCOHOLIC FATTY LIVER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DOWN REGULATION; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD; COMPARATIVE STUDY; FATTY LIVER; GENE EXPRESSION PROFILING; LIVER CIRRHOSIS; MASS SPECTROMETRY; RAT; TWO DIMENSIONAL GEL ELECTROPHORESIS; WISTAR RAT;

ANIMALIA; HEPATITIS C VIRUS; RATTUS; RODENTIA;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; C-REACTIVE PROTEIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FATTY LIVER; FATTY LIVER, ALCOHOLIC; GENE EXPRESSION PROFILING; LIVER CIRRHOSIS; RATS; RATS, WISTAR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 79960878590     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-52     Document Type: Article

References (35)

1. Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. Rouach H, Fataccioli V, Gentil M, French SW, Morimoto M, Nordmann R, Hepatology 1997 25 351 355 10.1002/hep.510250216 9021946 (Pubitemid 27069054)
2. Effect of ethanol on lipid metabolism in cultured hepatocytes. Grunnet N, Kondrup J, Dich J, Biochem J 1985 228 673 681 3927897 (Pubitemid 15011518)
3. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, Pudifin DJ, Lancet 1986 1 523 525 2869260 (Pubitemid 16138427)
4. Alcohol and oxidative liver injury. Dey A, Cederbaum AI, Hepatology 2006 43 63 74 10.1002/hep.20957 16447273
5. Diagnosis and therapy of alcoholic liver disease. Levitsky J, Mailliard ME, Semin Liver Dis 2004 24 233 247 10.1055/s-2004-832937 15349802 (Pubitemid 39167682)
6. Prognostic factors in severe alcoholic liver injury. Nara Liver Study Group. Fujimoto M, Uemura M, Kojima H, Ishii Y, Ann T, Sakurai S, Okuda K, Noguchi R, Adachi S, Kitano H, et al. Alcohol Clin Exp Res 1999 23 33S 38S 10.1111/j.1530-0277.1999.tb04531.x 10235276 (Pubitemid 29203196)
7. Serum C-reactive protein: a non-invasive marker of alcoholic hepatitis. Vanbiervliet G, Le Breton F, Rosenthal-Allieri MA, Gelsi E, Marine-Barjoan E, Anty R, Piche T, Benzaken S, Saint-Paul MC, Huet PM, Tran A, Scand J Gastroenterol 2006 41 1473 1479 10.1080/00365520600842195 17101579 (Pubitemid 44764409)
8. Serial measurement of serum C-reactive protein facilitates evaluation in alcoholic hepatitis. Gupta S, Slaughter S, Akriviadis EA, Valenzuela R, Deodhar SD, Hepatogastroenterology 1995 42 516 521 8751208
9. Increased serum tissue polypeptide specific antigen (TPS) in alcoholics: a possible marker of alcoholic hepatitis. Gonzalez-Quintela A, Mella C, Perez LF, Abdulkader I, Caparrini AM, Lojo S, Alcohol Clin Exp Res 2000 24 1222 1226 10.1111/j.1530-0277.2000.tb02087.x 10968661 (Pubitemid 30650941)
10. Increased plasma interleukin-6 concentrations in alcoholic hepatitis. Hill DB, Marsano L, Cohen D, Allen J, Shedlofsky S, McClain CJ, J Lab Clin Med 1992 119 547 552 1583411
11. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Unlu M, Morgan ME, Minden JS, Electrophoresis 1997 18 2071 2077 10.1002/elps.1150181133 9420172 (Pubitemid 27501267)
12. 2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer. Byrne JC, Downes MR, O'Donoghue N, O'Keane C, O'Neill A, Fan Y, Fitzpatrick JM, Dunn M, Watson RW, J Proteome Res 2009 8 942 957 10.1021/pr800570s 19093873
13. Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI. Ho AS, Cheng CC, Lee SC, Liu ML, Lee JY, Wang WM, Wang CC, J Biomed Sci 2010 17 58 10.1186/1423-0127-17-58 20630109
14. Application of 2D-DIGE in cancer proteomics toward personalized medicine. Kondo T, Hirohashi S, Methods Mol Biol 2009 577 135 154 10.1007/978-1-60761- 232-2-11 19718514
15. Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach. Orenes-Pinero E, Corton M, Gonzalez-Peramato P, Algaba F, Casal I, Serrano A, Sanchez-Carbayo M, J Proteome Res 2007 6 4440 4448 10.1021/pr070368w 17902641 (Pubitemid 350158519)
16. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. Keshavarzian A, Farhadi A, Forsyth CB, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ, J Hepatol 2009 50 538 547 19155080
17. Obesity, overweight, and weight gain over adult life are main determinants of elevated hs-CRP in a cohort of Mediterranean women. Gentile M, Panico S, Rubba F, Mattiello A, Chiodini P, Jossa F, Marotta G, Pauciullo P, Rubba P, Eur J Clin Nutr 2010 64 873 878 10.1038/ejcn.2010.69 20517327
18. CRP may be superior to anthropometric markers of obesity. Oda E, Circ J 2007 71 1332 author reply 1332-1333 10.1253/circj.71.1332 17652907
19. Markers of inflammation and cardiovascular disease: clinical applications of C-reactive protein determination. Martinez VB, Gonzalez-Juanatey JR, Am J Cardiovasc Drugs 2009 9 Suppl 1 3 7 20000881
20. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Ridker PM, Circulation 2003 107 363 369 10.1161/01.CIR.0000053730.47739.3C 12551853 (Pubitemid 36158034)
21. Alcohol consumption and plasma concentration of C-reactive protein. Albert MA, Glynn RJ, Ridker PM, Circulation 2003 107 443 447 10.1161/01.CIR.0000045669.16499.EC 12551869 (Pubitemid 36158047)
22. C-reactive protein: a critical update. Pepys MB, Hirschfield GM, J Clin Invest 2003 111 1805 1812 12813013 (Pubitemid 38057722)
23. Induction of glycosylation in human C-reactive protein under different pathological conditions. Das T, Sen AK, Kempf T, Pramanik SR, Mandal C, Mandal C, Biochem J 2003 373 345 355 10.1042/BJ20021701 12693993 (Pubitemid 36897838)
24. [Concentration of C-reactive protein, procalcitonin and alpha-1-antitrypsin in blood of neonates and infants with signs of inflammation]. Laskowska-Klita T, Czerwinska B, Med Wieku Rozwoj 2002 6 5 11 12177508
25. Serum alpha1-antitrypsin but not complement C3 and C4 predicts chronic inflammation in hemodialysis patients. Borawski J, Naumnik B, Mysliwiec M, Ren Fail 2003 25 589 593 10.1081/JDI-120022550 12911163 (Pubitemid 36944738)
26. Role of oxidative stress in alcohol-induced liver injury. Cederbaum AI, Lu Y, Wu D, Arch Toxicol 2009 83 519 548 10.1007/s00204-009-0432-0 19448996
27. Changes in cytochromes P-450, 2E1, 2B1, and 4A, and phospholipases A and C in the intragastric feeding rat model for alcoholic liver disease: relationship to dietary fats and pathologic liver injury. Nanji AA, Zhao S, Lamb RG, Dannenberg AJ, Sadrzadeh SM, Waxman DJ, Alcohol Clin Exp Res 1994 18 902 908 10.1111/j.1530-0277.1994.tb00058.x 7978103 (Pubitemid 24264112)
28. Cytochrome P4502E1 primes macrophages to increase TNF-alpha production in response to lipopolysaccharide. Cao Q, Mak KM, Lieber CS, Am J Physiol Gastrointest Liver Physiol 2005 289 95 107 10.1152/ajpgi.00383.2004 15961886 (Pubitemid 40944228)
29. CYP2E1 and oxidative liver injury by alcohol. Lu Y, Cederbaum AI, Free Radic Biol Med 2008 44 723 738 10.1016/j.freeradbiomed.2007.11.004 18078827
30. Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver disease. Naveau S, Cassard-Doulcier AM, Njike-Nakseu M, Bouchet-Delbos L, Barri-Ova N, Boujedidi H, Dauvois B, Balian A, Maitre S, Prevot S, et al. J Hepatol 2010 52 895 902 10.1016/j.jhep.2010.01.029 20399524
31. Serum haptoglobin: a novel marker of adiposity in humans. Chiellini C, Santini F, Marsili A, Berti P, Bertacca A, Pelosini C, Scartabelli G, Pardini E, Lopez-Soriano J, Centoni R, et al. J Clin Endocrinol Metab 2004 89 2678 2683 10.1210/jc.2003-031965 15181041 (Pubitemid 38766349)
32. Diagnostic value of serum haptoglobin protein as hepatocellular carcinoma candidate marker complementary to alpha fetoprotein. Shu H, Kang X, Guo K, Li S, Li M, Sun L, Gan L, Liu Y, Qin X, Oncol Rep 2010 24 1271 1276 20878120
33. Usefulness of non-invasive markers for predicting significant fibrosis in patients with chronic liver disease. Lee HH, Seo YS, Um SH, Won NH, Yoo H, Jung ES, Kwon YD, Park S, Keum B, Kim YS, et al. J Korean Med Sci 2010 25 67 74 10.3346/jkms.2010.25.1.67 20052350
34. The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease. Thabut D, Naveau S, Charlotte F, Massard J, Ratziu V, Imbert-Bismut F, Cazals-Hatem D, Abella A, Messous D, Beuzen F, et al. J Hepatol 2006 44 1175 1185 10.1016/j.jhep.2006.02.010 16580087
35. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Pasceri V, Willerson JT, Yeh ET, Circulation 2000 102 2165 2168 11056086